BRCA1 haploinsufficiency for replication stress suppression in primary cells

[1]  J. Yeo,et al.  CtIP mediates replication fork recovery in a FANCD2-regulated manner. , 2014, Human molecular genetics.

[2]  Ralph Scully,et al.  BRCA1 controls homologous recombination at Tus/Ter-stalled mammalian replication forks , 2014, Nature.

[3]  M. Salto‐Tellez,et al.  BRCA1 deficiency exacerbates estrogen-induced DNA damage and genomic instability. , 2014, Cancer research.

[4]  N. Mailand,et al.  ATR Prohibits Replication Catastrophe by Preventing Global Exhaustion of RPA , 2013, Cell.

[5]  H. Pospiech,et al.  Heterozygous mutations in PALB2 cause DNA replication and damage response defects , 2013, Nature Communications.

[6]  Linda Z. Shi,et al.  CtIP Is Required to Initiate Replication-Dependent Interstrand Crosslink Repair , 2012, PLoS genetics.

[7]  D. Livingston,et al.  Mechanisms of BRCA1 tumor suppression. , 2012, Cancer discovery.

[8]  Hong Wu,et al.  A distinct replication fork protection pathway connects Fanconi anemia tumor suppressors to RAD51-BRCA1/2. , 2012, Cancer cell.

[9]  M. Gönen,et al.  Evolutionary pathways in BRCA1-associated breast tumors. , 2012, Cancer discovery.

[10]  R. Bristow,et al.  Discordance between phosphorylation and recruitment of 53BP1 in response to DNA double-strand breaks , 2012, Cell cycle.

[11]  V. Costanzo,et al.  RAD51 and MRE11 dependent reassembly of uncoupled CMG helicase complex at collapsed replication forks , 2011, Nature Structural &Molecular Biology.

[12]  D. Livingston,et al.  BRCA1 is required for postreplication repair after UV-induced DNA damage. , 2011, Molecular cell.

[13]  Lei Li.  BRCA1 forks over new roles in DNA-damage response- before and beyond the breaks. , 2011, Molecular cell.

[14]  Hiroyuki Konishi,et al.  Mutation of a single allele of the cancer susceptibility gene BRCA1 leads to genomic instability in human breast epithelial cells , 2011, Proceedings of the National Academy of Sciences.

[15]  F. Gage,et al.  BRCA 1 tumor suppression occurs via heterochromatin mediated silencing , 2011 .

[16]  A. Egashira,et al.  Double-Strand Break Repair-Independent Role for BRCA2 in Blocking Stalled Replication Fork Degradation by MRE11 , 2011, Cell.

[17]  M. Teitell,et al.  Regulation of cell differentiation by the DNA damage response. , 2011, Trends in cell biology.

[18]  E. Lander,et al.  Genetic predisposition directs breast cancer phenotype by dictating progenitor cell fate. , 2011, Cell stem cell.

[19]  S. Schnitt,et al.  Mapping the cellular and molecular heterogeneity of normal and malignant breast tissues and cultured cell lines , 2010, Breast Cancer Research.

[20]  D. Hunting,et al.  DNA interstrand cross-links induced by ionizing radiation: an unsung lesion. , 2010, Mutation research.

[21]  T. Halazonetis,et al.  Genomic instability — an evolving hallmark of cancer , 2010, Nature Reviews Molecular Cell Biology.

[22]  T. Helleday,et al.  Hydroxyurea-Stalled Replication Forks Become Progressively Inactivated and Require Two Different RAD51-Mediated Pathways for Restart and Repair , 2010, Molecular cell.

[23]  Junjie Chen,et al.  BRCA1 and its toolbox for the maintenance of genome integrity , 2010, Nature Reviews Molecular Cell Biology.

[24]  Keith L. Ligon,et al.  Profiling Critical Cancer Gene Mutations in Clinical Tumor Samples , 2009, PloS one.

[25]  J. Parvin,et al.  The BRCA1‐dependent ubiquitin ligase, γ‐tubulin, and centrosomes , 2009, Environmental and molecular mutagenesis.

[26]  S. Fox,et al.  Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers , 2009, Nature Medicine.

[27]  Bernard T. Lee,et al.  Altered proliferation and differentiation properties of primary mammary epithelial cells from BRCA1 mutation carriers. , 2009, Cancer research.

[28]  P. Borst,et al.  High sensitivity of BRCA1-deficient mammary tumors to the PARP inhibitor AZD2281 alone and in combination with platinum drugs , 2008, Proceedings of the National Academy of Sciences.

[29]  K. Cimprich,et al.  ATR: an essential regulator of genome integrity , 2008, Nature Reviews Molecular Cell Biology.

[30]  Jiri Bartek,et al.  An Oncogene-Induced DNA Damage Model for Cancer Development , 2008, Science.

[31]  S. Merajver,et al.  BRCA1 regulates human mammary stem/progenitor cell fate , 2008, Proceedings of the National Academy of Sciences.

[32]  K. Gunsalus,et al.  Network modeling links breast cancer susceptibility and centrosome dysfunction. , 2007, Nature genetics.

[33]  J. Bartek,et al.  DNA Damage Response as an Anti-Cancer Barrier: Damage Threshold and the Concept of 'Conditional Haploinsufficiency' , 2007, Cell cycle.

[34]  J. Peterse,et al.  Somatic loss of BRCA1 and p53 in mice induces mammary tumors with features of human BRCA1-mutated basal-like breast cancer , 2007, Proceedings of the National Academy of Sciences.

[35]  Steven P Gygi,et al.  Abraxas and RAP80 Form a BRCA1 Protein Complex Required for the DNA Damage Response , 2007, Science.

[36]  S. Gabriel,et al.  High-throughput oncogene mutation profiling in human cancer , 2007, Nature Genetics.

[37]  Tom Walsh,et al.  Ten genes for inherited breast cancer. , 2007, Cancer cell.

[38]  David M. Livingston,et al.  The BRCA1/BARD1 Heterodimer Modulates Ran-Dependent Mitotic Spindle Assembly , 2006, Cell.

[39]  Olga Anczuków,et al.  The 185delAG mutation (c.68_69delAG) in the BRCA1 gene triggers translation reinitiation at a downstream AUG codon , 2006, Human mutation.

[40]  V. Costanzo,et al.  ATM and ATR promote Mre11 dependent restart of collapsed replication forks and prevent accumulation of DNA breaks , 2006, The EMBO journal.

[41]  Abdellah Belmaaza,et al.  BRCA1 regulates RAD51 function in response to DNA damage and suppresses spontaneous sister chromatid replication slippage: implications for sister chromatid cohesion, genome stability, and carcinogenesis. , 2005, Cancer research.

[42]  S. Powell,et al.  The Role of the BRCA1 Tumor Suppressor in DNA Double-Strand Break Repair , 2005, Molecular Cancer Research.

[43]  T. Helleday,et al.  Poly(ADP-ribose) Polymerase (PARP-1) in Homologous Recombination and as a Target for Cancer Therapy , 2005, Cell cycle.

[44]  D. Cortez.  Unwind and slow down: checkpoint activation by helicase and polymerase uncoupling. , 2005, Genes & development.

[45]  T. Ørntoft,et al.  DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis , 2005, Nature.

[46]  Dimitris Kletsas,et al.  Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions , 2005, Nature.

[47]  Thomas Helleday,et al.  Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase , 2005, Nature.

[48]  E. Li,et al.  Ring1b-mediated H2A Ubiquitination Associates with Inactive X Chromosomes and Is Involved in Initiation of X Inactivation* , 2004, Journal of Biological Chemistry.

[49]  Jiri Bartek,et al.  Cell-cycle checkpoints and cancer , 2004, Nature.

[50]  W. Foulkes,et al.  BRCA1 and BRCA2: 1994 and beyond , 2004, Nature Reviews Cancer.

[51]  M. King,et al.  Breast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA1 and BRCA2 , 2003, Science.

[52]  Stephen J. Elledge,et al.  Sensing DNA Damage Through ATRIP Recognition of RPA-ssDNA Complexes , 2003, Science.

[53]  Stephen C. West,et al.  Molecular views of recombination proteins and their control , 2003, Nature Reviews Molecular Cell Biology.

[54]  G. Mills,et al.  Evidence of haplotype insufficiency in human cells containing a germline mutation in BRCA1 or BRCA2 , 2002, International journal of cancer.

[55]  Ashok R Venkitaraman,et al.  Cancer Susceptibility and the Functions of BRCA1 and BRCA2 , 2002, Cell.

[56]  J. Milner,et al.  Analysis of nucleotide excision repair by detection of single-stranded DNA transients. , 2001, Carcinogenesis.

[57]  P O'Neill,et al.  Computational Approach for Determining the Spectrum of DNA Damage Induced by Ionizing Radiation , 2001, Radiation research.

[58]  R. Kanaar,et al.  Repair of DNA interstrand cross-links. , 2001, Mutation research.

[59]  M. Jasin,et al.  Homology-directed dna repair, mitomycin-c resistance, and chromosome stability is restored with correction of a Brca1 mutation. , 2001, Cancer research.

[60]  Bo Xu,et al.  Involvement of Brca1 in S-Phase and G2-Phase Checkpoints after Ionizing Irradiation , 2001, Molecular and Cellular Biology.

[61]  D. Livingston,et al.  In search of the tumour-suppressor functions of BRCA1 and BRCA2 , 2000, Nature.

[62]  Alexander Kinev,et al.  BRCA1 Is Associated with a Human SWI/SNF-Related Complex Linking Chromatin Remodeling to Breast Cancer , 2000, Cell.

[63]  B. Koller,et al.  Brca1 controls homology-directed DNA repair. , 1999, Molecular cell.

[64]  C. Wang,et al.  Association of BRCA1 with the hRad50-hMre11-p95 complex and the DNA damage response. , 1999, Science.

[65]  Sean V Tavtigian,et al.  Characterization of a carboxy-terminal BRCA1 interacting protein , 1998, Oncogene.

[66]  Yonghong Xiao,et al.  Association of BRCA1 with Rad51 in Mitotic and Meiotic Cells , 1997, Cell.

[67]  Kun Huang,et al.  DNA Damage and Cellular Stress Responses KIAA 0101 Interacts with BRCA 1 and Regulates Centrosome Number , 2011 .

[68]  R. Greenberg,et al.  Multifactorial contributions to an acute DNA damage response by BRCA1/BARD1-containing complexes. , 2006, Genes & development.

[69]  U. Hagen.  Current aspects on the radiation induced base damage in DNA , 1986, Radiation and environmental biophysics.